Gambardella Ivancarmine, Lau Christopher, Gaudino Mario F L, Worku Berhane, Rahouma Mohamad, Tranbaugh Robert F, Girardi Leonard N
Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY.
Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY.
J Vasc Surg. 2021 Oct;74(4):1099-1108.e4. doi: 10.1016/j.jvs.2021.02.030. Epub 2021 Mar 5.
In the present study, we sought to discern the effects of splanchnic occlusive disease (SOD; renal, superior mesenteric, and/or celiac axis arteries) on spinal cord injury (SCI; paraparesis or paraplegia) and major adverse events (MAE) after descending thoracic aneurysm (DTA) and thoracoabdominal aortic aneurysm (TAAA) open repair.
Patients who had undergone DTA/TAAA repair at our institution were dichotomized according to the presence of SOD, which was investigated as a predictive factor of our primary (SCI) and secondary (operative mortality, myocardial infarction, stroke, tracheostomy, de novo dialysis, MAE, survival) endpoints. Risk adjustment used both propensity score matching and multivariable logistic regression.
From July 1997 to October 2019, 888 patients had undergone DTA/TAAA repair, of whom 19 were excluded from our analysis for missing data. SOD was absent in 712 patients and present in 157 patients. The patients with SOD had presented with a greater incidence of preoperative renal impairment (61 [38.9%] vs 175 [24.6%]; P < .01) and peripheral arterial disease (60 [38.2%] vs 162 [22.8%]; P < .01] and decreased left ventricular ejection fraction (45%; interquartile range, 10%; vs 50%; interquartile range, 4%; P < .01). The etiology of aortic disease was more frequently dissection in the SOD group (56.1% vs 43.7%) and more frequently nondissecting aneurysm in the non-SOD group (56.3% vs 43.9%; P < .01). Patients without SOD had presented with aneurysms more cranially located (DTA, 34.0% vs 7.6%; extent I TAAA, 44.0% vs 7.6%). In contrast, patients with SOD had presented with aneurysms more caudally located (extent II TAAA, 36.9% vs 8.6%; extent III TAAA, 30.6% vs 11.0%; extent IV TAAA, 17.2% vs 2.5%; P < .01). Propensity score matching led to 144 pairs, with SOD significantly associated with SCI (10 [6.9%] vs 2 [1.4%]; P = .03) and MAE (47 [32.6%] vs 26 [15%]; P < .01). Ten-year survival was reduced in those with SOD (31.5% vs 45.2%; P < .01). Conditional multivariable regression confirmed SOD to be a predictor of SCI in the matched sample (odds ratio, 6.60; P = .02).
Our results have shown that SOD is a significant predictor of SCI in patients undergoing open DTA/TAAA repair. The investigation of measures to prolong neuronal ischemia tolerance (eg, hypothermia) is warranted for such patients.
在本研究中,我们试图了解内脏闭塞性疾病(SOD;肾动脉、肠系膜上动脉和/或腹腔干动脉)对降主动脉瘤(DTA)和胸腹主动脉瘤(TAAA)开放修复术后脊髓损伤(SCI;轻截瘫或截瘫)和主要不良事件(MAE)的影响。
在我们机构接受DTA/TAAA修复的患者根据是否存在SOD进行二分法分类,SOD作为我们主要(SCI)和次要(手术死亡率、心肌梗死、中风、气管切开术、新发透析、MAE、生存率)终点的预测因素进行研究。风险调整采用倾向评分匹配和多变量逻辑回归。
从1997年7月至2019年10月,888例患者接受了DTA/TAAA修复,其中19例因数据缺失被排除在我们的分析之外。712例患者无SOD,157例患者有SOD。有SOD的患者术前肾功能损害发生率更高(61例[38.9%]对175例[24.6%];P <.01)、外周动脉疾病发生率更高(60例[38.2%]对162例[22.8%];P <.01)且左心室射血分数降低(45%;四分位间距,10%;对50%;四分位间距,4%;P <.01)。主动脉疾病的病因在SOD组中更常见于夹层(56.1%对43.7%),在非SOD组中更常见于非夹层动脉瘤(56.3%对43.9%;P <.01)。无SOD的患者动脉瘤位置更靠上(DTA,34.0%对7.6%;I型TAAA,44.0%对7.6%)。相比之下,有SOD的患者动脉瘤位置更靠下(II型TAAA,36.9%对8.6%;III型TAAA,30.6%对11.0%;IV型TAAA,17.2%对2.5%;P <.01)。倾向评分匹配产生了144对,SOD与SCI(10例[6.9%]对2例[1.4%];P =.03)和MAE(47例[32.6%]对26例[15%];P <.01)显著相关。有SOD的患者10年生存率降低(31.5%对45.2%;P <.01)。条件多变量回归证实SOD是匹配样本中SCI的预测因素(比值比,6.60;P =.02)。
我们的结果表明,SOD是接受开放DTA/TAAA修复患者SCI的重要预测因素。对于此类患者,有必要研究延长神经元缺血耐受性的措施(如低温)。